Adage Capital Partners Portfolio holdings
AUM
$59.3B
1-Year Return
26.26%
This Quarter Return
+7.47%
1 Year Return
+26.26%
3 Year Return
+130.73%
5 Year Return
+248.99%
10 Year Return
+658.76%
AUM
$56.6B
AUM Growth
+$2.63B
(+4.9%)
Cap. Flow
-$236M
Cap. Flow
% of AUM
-0.42%
Top 10 Holdings %
Top 10 Hldgs %
29.54%
Holding
970
New
110
Increased
283
Reduced
395
Closed
105
Top Buys
| 1 |
HES
Hess
HES
|
$285M |
| 2 |
3M
MMM
|
$208M |
| 3 |
Bristol-Myers Squibb
BMY
|
$187M |
| 4 |
Dover
DOV
|
$150M |
| 5 |
Waste Management
WM
|
$145M |
Top Sells
| 1 |
CSX Corp
CSX
|
$201M |
| 2 |
Merck
MRK
|
$191M |
| 3 |
Deere & Co
DE
|
$122M |
| 4 |
RB Global
RBA
|
$108M |
| 5 |
ConocoPhillips
COP
|
$106M |
Sector Composition
| 1 | Technology | 28.49% |
| 2 | Healthcare | 16.13% |
| 3 | Financials | 10.57% |
| 4 | Consumer Discretionary | 9.62% |
| 5 | Industrials | 8.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
576
Harmony Biosciences
HRMY
$2.07B
| $12M | 0.02% |
300,000
+250,000
| +500% | +$10M |
|
577
NextDecade
NEXT
$2.8B
| $12M | 0.02% |
2,546,953
-53,047
| -2% | -$250K |
|
578
Powell Industries
POWL
$3.24B
| $12M | 0.02% |
54,000
-95,503
| -64% | -$21.2M |
|
579
Akamai
AKAM
$11.3B
| $11.9M | 0.02% |
117,800
+56,700
| +93% | +$5.72M |
|
580
Antero Resources
AR
$10.1B
| $11.8M | 0.02% |
410,696
-770,000
| -65% | -$22.1M |
|
|
LINE
581
Lineage, Inc. Common Stock
LINE
$9.29B
| $11.8M | 0.02% |
+150,000
| New | +$11.8M |
|
582
Relay Therapeutics
RLAY
$710M
| $11.7M | 0.02% |
+1,650,000
| New | +$11.7M |
|
583
LXP Industrial Trust
LXP
$2.71B
| $11.6M | 0.02% |
1,150,000
-50,000
| -4% | -$503K |
|
584
American Healthcare REIT
AHR
$7.2B
| $11.2M | 0.02% |
+430,000
| New | +$11.2M |
|
585
Interpublic Group of Companies
IPG
$9.94B
| $11.2M | 0.02% |
353,989
-8,000
| -2% | -$253K |
|
586
Arbutus Biopharma
ABUS
$805M
| $11.2M | 0.02% |
2,900,941
-99,059
| -3% | -$381K |
|
587
Larimar Therapeutics
LRMR
$337M
| $11.1M | 0.02% |
1,700,877
+329,377
| +24% | +$2.16M |
|
588
FMC
FMC
$4.72B
| $11.1M | 0.02% |
167,700
+48,000
| +40% | +$3.17M |
|
589
BP
BP
$87.4B
| $11M | 0.02% |
350,000
+100,000
| +40% | +$3.14M |
|
590
Structure Therapeutics
GPCR
$1.27B
| $11M | 0.02% |
250,000
-963,099
| -79% | -$42.3M |
|
591
Corbus Pharmaceuticals
CRBP
$121M
| $10.9M | 0.02% |
528,937
+128,937
| +32% | +$2.66M |
|
|
AUTL
592
Autolus Therapeutics
AUTL
$389M
| $10.7M | 0.02% |
2,950,000
-250,000
| -8% | -$908K |
|
593
Informatica
INFA
$7.55B
| $10.5M | 0.02% |
415,000
-4,701
| -1% | -$119K |
|
594
National Grid
NGG
$69.6B
| $10.5M | 0.02% |
156,924
-130,770
| -45% | -$8.71M |
|
595
Nutanix
NTNX
$18.7B
| $10.4M | 0.02% |
+175,000
| New | +$10.4M |
|
596
HubSpot
HUBS
$25.7B
| $10.4M | 0.02% |
19,500
-10,500
| -35% | -$5.58M |
|
597
Fortive
FTV
$16.2B
| $10.3M | 0.02% |
130,629
-939,835
| -88% | -$74.2M |
|
598
Precigen
PGEN
$1.3B
| $10.3M | 0.02% |
+10,865,405
| New | +$10.3M |
|
599
Elanco Animal Health
ELAN
$9.16B
| $10.3M | 0.02% |
700,000
-696,643
| -50% | -$10.2M |
|
600
Symbotic
SYM
$5.37B
| $10.1M | 0.02% |
415,000
-183,000
| -31% | -$4.46M |
|